BPH - Benign Prostatic Enlargement - Results from #2400

REVIEW UroToday

Role of phosphodiesterase type 5 inhibitors for lower urinary tract symptoms - Abstract February 18, 2013

Efficacy and safety of orally disintegrating tamsulosin tablets in Taiwanese patients with benign prostatic hyperplasia - Abstract February 15, 2013

A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: Finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride February 14, 2013

Update on the sexual impact of treatment for benign prostatic hyperplasia - Abstract February 13, 2013

Empirical evaluation of grouping of lower urinary tract symptoms: Principal component analysis of Tampere Ageing Male Urological Study data - Abstract February 13, 2013

Safety and toxicity of saw palmetto in the CAMUS trial - Abstract February 12, 2013

Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma - Abstract February 11, 2013

Noninvasive urodynamic evaluation - Abstract February 11, 2013

The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients - Abstract February 8, 2013

Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: Comparison of prostate volumes 100 cc - Abstract February 7, 2013

Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss - Abstract February 6, 2013

Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia - Abstract February 4, 2013

High-intensity diode laser in combination with bipolar transurethral resection of the prostate: A new strategy for the treatment of large prostates (>80 ml) - Abstract February 1, 2013

Tadalafil : In the treatment of signs and symptoms of benign prostatic hyperplasia with or without erectile dysfunction - Abstract January 31, 2013

The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia - Abstract January 31, 2013

Relationships among participant International Prostate Symptom Score, Benign Prostatic Hyperplasia Impact Index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms - Abstract January 30, 2013

Office evaluation of male patients with lower urinary tract symptoms - Abstract January 28, 2013

Population based trends in the surgical treatment of benign prostatic hyperplasia - Abstract January 25, 2013

Can we predict the outcome of 532 nm laser photoselective vaporization of the prostate? Time to event analysis - Abstract January 24, 2013

Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: Randomized study comparing two doses - Abstract January 23, 2013

Page 121 of 140